Halozyme Therapeutics (HALO)
NASDAQ:HALO
US Market
Advertisement

Halozyme (HALO) Ratios

Compare
1,112 Followers

Halozyme Ratios

HALO's free cash flow for Q3 2025 was $0.84. For the 2025 fiscal year, HALO's free cash flow was decreased by $ and operating cash flow was $0.63. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.59 6.64 5.65 7.91 1.32
Quick Ratio
1.37 5.50 4.88 7.45 1.17
Cash Ratio
0.50 1.05 1.79 1.01 0.35
Solvency Ratio
0.42 0.22 0.15 0.45 0.31
Operating Cash Flow Ratio
0.73 3.45 1.84 2.56 0.13
Short-Term Operating Cash Flow Coverage
0.86 0.00 18.01 3.35 0.14
Net Current Asset Value
$ -388.57M$ -903.04M$ -932.70M$ 18.81M$ 125.89M
Leverage Ratios
Debt-to-Assets Ratio
0.68 0.86 0.82 0.79 0.68
Debt-to-Equity Ratio
3.00 17.89 8.87 4.45 2.63
Debt-to-Capital Ratio
0.75 0.95 0.90 0.82 0.72
Long-Term Debt-to-Capital Ratio
0.61 0.95 0.90 0.80 0.00
Financial Leverage Ratio
4.41 20.68 10.85 5.61 3.84
Debt Service Coverage Ratio
1.01 20.53 8.87 4.26 0.37
Interest Coverage Ratio
41.53 17.99 15.79 36.66 7.08
Debt to Market Cap
0.19 0.31 0.19 0.16 0.07
Interest Debt Per Share
13.04 11.51 11.13 6.29 3.07
Net Debt to EBITDA
1.23 3.06 4.03 2.93 1.63
Profitability Margins
Gross Profit Margin
84.55%76.80%78.90%81.64%83.79%
EBIT Margin
61.45%44.27%40.28%62.24%53.91%
EBITDA Margin
71.32%54.50%47.80%58.43%57.16%
Operating Profit Margin
59.33%40.71%40.53%62.24%53.91%
Pretax Profit Margin
60.02%42.01%37.71%56.06%48.32%
Net Profit Margin
47.91%33.96%30.62%90.84%48.24%
Continuous Operations Profit Margin
47.91%33.96%30.62%90.84%48.24%
Net Income Per EBT
79.83%80.84%81.20%162.04%99.83%
EBT Per EBIT
101.16%103.19%93.04%90.07%89.63%
Return on Assets (ROA)
26.81%16.25%10.98%36.46%22.26%
Return on Equity (ROE)
141.55%336.00%119.04%204.47%85.46%
Return on Capital Employed (ROCE)
53.28%20.83%15.64%27.95%90.99%
Return on Invested Capital (ROIC)
28.10%16.84%13.36%42.40%26.83%
Return on Tangible Assets
40.90%33.38%22.82%36.45%22.26%
Earnings Yield
7.44%5.78%2.60%7.12%2.22%
Efficiency Ratios
Receivables Turnover
3.59 3.54 2.86 4.87 2.74
Payables Turnover
12.50 16.28 7.87 52.83 22.49
Inventory Turnover
1.03 1.51 1.39 1.51 0.71
Fixed Asset Turnover
17.40 11.06 8.74 50.41 25.26
Asset Turnover
0.56 0.48 0.36 0.40 0.46
Working Capital Turnover Ratio
1.68 1.34 0.93 0.94 0.91
Cash Conversion Cycle
425.53 322.79 343.75 309.68 628.36
Days of Sales Outstanding
101.62 103.09 127.77 74.90 133.30
Days of Inventory Outstanding
353.10 242.12 262.34 241.69 511.28
Days of Payables Outstanding
29.19 22.42 46.36 6.91 16.23
Operating Cycle
454.72 345.21 390.11 316.59 644.58
Cash Flow Ratios
Operating Cash Flow Per Share
5.21 2.95 1.75 2.13 0.41
Free Cash Flow Per Share
5.14 2.83 1.72 2.12 0.39
CapEx Per Share
0.07 0.12 0.04 0.01 0.02
Free Cash Flow to Operating Cash Flow
0.99 0.96 0.98 1.00 0.95
Dividend Paid and CapEx Coverage Ratio
71.09 25.41 49.92 205.52 22.15
Capital Expenditure Coverage Ratio
71.09 25.41 49.92 205.52 22.15
Operating Cash Flow Coverage Ratio
0.40 0.26 0.16 0.34 0.14
Operating Cash Flow to Sales Ratio
0.49 0.47 0.36 0.68 0.21
Free Cash Flow Yield
7.51%7.66%3.02%5.27%0.91%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
13.43 17.32 38.52 14.04 45.07
Price-to-Sales (P/S) Ratio
6.46 5.88 11.80 12.76 21.74
Price-to-Book (P/B) Ratio
15.87 58.18 45.86 28.71 38.51
Price-to-Free Cash Flow (P/FCF) Ratio
13.32 13.06 33.09 18.98 109.87
Price-to-Operating Cash Flow Ratio
13.09 12.55 32.43 18.89 104.90
Price-to-Earnings Growth (PEG) Ratio
1.47 0.39 -0.80 0.07 -0.16
Price-to-Fair Value
15.87 58.18 45.86 28.71 38.51
Enterprise Value Multiple
10.28 13.84 28.71 24.76 39.66
Enterprise Value
9.12B 6.26B 9.06B 6.41B 6.07B
EV to EBITDA
10.28 13.84 28.71 24.76 39.66
EV to Sales
7.33 7.55 13.72 14.47 22.67
EV to Free Cash Flow
15.13 16.76 38.50 21.52 114.58
EV to Operating Cash Flow
14.92 16.10 37.73 21.42 109.40
Tangible Book Value Per Share
-2.23 -6.11 -5.74 1.40 1.11
Shareholders’ Equity Per Share
4.30 0.64 1.24 1.40 1.11
Tax and Other Ratios
Effective Tax Rate
0.20 0.19 0.19 -0.62 <0.01
Revenue Per Share
10.60 6.29 4.82 3.15 1.96
Net Income Per Share
5.08 2.13 1.48 2.86 0.95
Tax Burden
0.80 0.81 0.81 1.62 1.00
Interest Burden
0.98 0.95 0.94 0.90 0.90
Research & Development to Revenue
0.06 0.09 0.10 0.08 0.13
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.04 0.04 0.04 0.05 0.06
Income Quality
1.03 1.38 1.19 0.74 0.43
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis